Agencies
Services
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 17, 2014
| Drug Name | Review Type | Class | Manufacturer |
|---|---|---|---|
| Otezla | New Drug Initial Review | Phosphodiesterase 4 Inhibitor | Celgene |
| Hemangeol | New Drug Initial Review | Beta-Adrenergic Blocker | Pierre Fabre |
| Opsumit | New Drug Initial Review | Pulmonary Aterial Hypertension | Actelion |
| Orenitram ER | New Drug Initial Review | Pulmonary Aterial Hypertension | United Therapeutics |
| Mycamine | New Drug Initial Review | Anti-fungal | Astellas |
| Ambisome | New Drug Initial Review | Anti-fungal | Astellas |
| Brilinta | PDL Appeal | Platelet Aggregation Inhibitor | Astra Zeneca |